Creating a “bridge” between UMass Chan Medical School and the external life science ecosystem to support innovative research, protect intellectual property, and facilitate commercialization to help our community, the Commonwealth and the world.
Sponsored research agreements
To facilitate research and partnership with philanthropic, public agencies or commercial enterprises
Protecting Intellectual Property (IP)
Filing and prosecuting patents and protecting copyright globally
Licensing
Creative licensing structures for new assets or platforms
Jun Xie, PhD, and Guangping Gao, PhD, received $500,000 from Chengdu Origen Biotechnology Co. Ltd., a subsidiary of Chengdu Kanghong Pharmaceutical Group, to help advance gene therapy by improving gene delivery vehicle transduction efficiency.
Ambros honored for discovery of microRNA and its role in post-transcriptional gene regulation
Oct 7, 2024
Reach out now!
We will quickly gather your project goals and answer any questions you may have to arrange an optimal engagement.
Working with BRIDGE
The New Ventures (NV) group is the first point of contact for UMass Chan researchers and external partners alike. This group is responsible for proactively scouting UMass Chan Medical School to identify and evaluate commercializable assets and platform technology and match them with potential partners in biotech, pharma and investor ecosystem.